Physician profile
David Mathes
NPI 1194761833
$103,344.53
in general payments reported to CMS, 2019-2025
27 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,899 · 2020: $669 · 2021: $2,640 · 2022: $5,808 · 2023: $6,959 · 2024: $26K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Food and Beverage: $25K · Travel and Lodging: $8,597 · Honoraria: $1,500 · Entertainment: $96.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,181.25 |
| Food and Beverage | $24,954.16 |
| Travel and Lodging | $8,596.54 |
| Honoraria | $1,500.00 |
| Entertainment | $96.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $60,949.05 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Novo Nordisk As | $14,457.69 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $5,681.08 | 2022-2025 | |
| Sientra, INC. | $4,858.21 | 2019-2022 | |
| Davol INC. | $2,778.72 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Abbvie INC. | $2,246.45 | 2023-2025 | |
| Allergan, INC. | $2,147.80 | 2019-2022 | |
| Mentor Worldwide LLC | $1,951.92 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Bimini Technologies LLC | $1,500.00 | 2025 | |
| Motiva USA, LLC | $990.67 | 2024-2025 | |
| Becton, Dickinson and Company | $910.80 | 2024-2025 | Phasix Mesh |
| Stryker Corporation | $747.93 | 2019-2025 | Molli, 1788 |
| Rti Surgical, INC | $740.33 | 2023-2025 | |
| Axogen | $463.23 | 2019-2025 | |
| Bone Support INC. | $442.86 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $442.44 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $441.69 | 2022-2024 | Monocryl |
| Depuy Synthes Sales INC. | $402.55 | 2020-2025 | Matrixmidface, Na |
| Kls-Martin L.P. | $308.22 | 2024 | |
| Polynovo North America LLC | $178.65 | 2023 | |
| Next Science LLC | $137.13 | 2025 | Xperience, Blastx |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Aroa Biosurgery Incorporated | $109.45 | 2024 | |
| Access Pro Medical, LLC | $104.11 | 2025 | Matriderm |
| Avita Medical Americas, LLC | $103.60 | 2024 | |
| Bard Peripheral Vascular, INC. | $66.11 | 2021 | |
| Vioptix INC | $58.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mathes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.